Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joon Kang

Showing results (221-230 of 235) with videos related to

Pageof 24
Sort By:
Molecular Biology Reports|May 12, 2012
ATM mediates interdependent activation of p53 and ERK through formation of a ternary complex with p-p53 and p-ERK in response to DNA damageJee-In Heo, Soo-Jin Oh, Yoon-Jung Kho, et al.
Cancer Research and Treatment|February 7, 2017
Can We Skip Intraoperative Evaluation of Sentinel Lymph Nodes? Nomogram Predicting Involvement of Three or More Axillary Lymph Nodes before Breast Cancer SurgerySoo Kyung Ahn, Min Kyoon Kim, Jongjin Kim, et al.
Journal of Breast Cancer|December 2, 2024
Breast Cancer Statistics in Korea, 2021Chihwan David Cha, Chan Sub Park, Hee-Chul Shin, et al.
Biochemical and Biophysical Research Communications|July 7, 2009
Suppression of thymus- and activation-regulated chemokine (TARC/CCL17) production by 1,2,3,4,6-penta-O-galloyl-beta-D-glucose via blockade of NF-kappaB and STAT1 activation in the HaCaT cellsSung Mi Ju, Ha Yong Song, Su Jin Lee, et al.
Breast Cancer Research and Treatment|August 3, 2017
Outcome following sentinel lymph node biopsy-guided decisions in breast cancer patients with conversion from positive to negative axillary lymph nodes after neoadjuvant chemotherapyYoung-Joon Kang, Wonshik Han, Soojin Park, et al.
Clinical Breast Cancer|May 31, 2018
Oncologic Safety of Gonadotropin-Releasing Hormone Agonist for Ovarian Function Protection During Breast Cancer ChemotherapyHee Jeong Kim, Moo Hyun Lee, Jeong Eon Lee, et al.
Breast Cancer Research : BCR|April 10, 2026
Contributing factors of contralateral breast cancer in patients with BRCA mutation (ON-BRCA II study, KoREa-BSG 11)Seon-Hi Shin, Sung Gwe Ahn, Jai Min Ryu, et al.
Metabolism: Clinical and Experimental|February 2, 2020
Sex specific effect of ATPase inhibitory factor 1 on body weight: studies in high fat diet induced obese mice and genetic association studies in humansSo-Young Kwak, InHyeok Chung, Joon Kang, et al.
JAMA Network Open|May 14, 2025
Long-Term Oncologic Outcome of Breast-Conserving Treatment in Patients With Breast Cancer With BRCA VariantsJanghee Lee, Jai Min Ryu, Hong Kyu Kim, et al.
Breast (Edinburgh, Scotland)|June 17, 2025
Body mass index and progesterone receptor in postmenopausal ER-positive/HER2-negative breast cancer: A nation-wide study in Korean breast cancer society and the multi-institutional cohortJanghee Lee, Soong June Bae, Hong Kyu Kim, et al.
Pageof 24

Showing results (221-230 of 235) with videos related to

Sort By:
Pageof 24
Molecular Biology Reports|May 12, 2012
ATM mediates interdependent activation of p53 and ERK through formation of a ternary complex with p-p53 and p-ERK in response to DNA damageJee-In Heo, Soo-Jin Oh, Yoon-Jung Kho, et al.
Cancer Research and Treatment|February 7, 2017
Can We Skip Intraoperative Evaluation of Sentinel Lymph Nodes? Nomogram Predicting Involvement of Three or More Axillary Lymph Nodes before Breast Cancer SurgerySoo Kyung Ahn, Min Kyoon Kim, Jongjin Kim, et al.
Journal of Breast Cancer|December 2, 2024
Breast Cancer Statistics in Korea, 2021Chihwan David Cha, Chan Sub Park, Hee-Chul Shin, et al.
Biochemical and Biophysical Research Communications|July 7, 2009
Suppression of thymus- and activation-regulated chemokine (TARC/CCL17) production by 1,2,3,4,6-penta-O-galloyl-beta-D-glucose via blockade of NF-kappaB and STAT1 activation in the HaCaT cellsSung Mi Ju, Ha Yong Song, Su Jin Lee, et al.
Breast Cancer Research and Treatment|August 3, 2017
Outcome following sentinel lymph node biopsy-guided decisions in breast cancer patients with conversion from positive to negative axillary lymph nodes after neoadjuvant chemotherapyYoung-Joon Kang, Wonshik Han, Soojin Park, et al.
Clinical Breast Cancer|May 31, 2018
Oncologic Safety of Gonadotropin-Releasing Hormone Agonist for Ovarian Function Protection During Breast Cancer ChemotherapyHee Jeong Kim, Moo Hyun Lee, Jeong Eon Lee, et al.
Breast Cancer Research : BCR|April 10, 2026
Contributing factors of contralateral breast cancer in patients with BRCA mutation (ON-BRCA II study, KoREa-BSG 11)Seon-Hi Shin, Sung Gwe Ahn, Jai Min Ryu, et al.
Metabolism: Clinical and Experimental|February 2, 2020
Sex specific effect of ATPase inhibitory factor 1 on body weight: studies in high fat diet induced obese mice and genetic association studies in humansSo-Young Kwak, InHyeok Chung, Joon Kang, et al.
JAMA Network Open|May 14, 2025
Long-Term Oncologic Outcome of Breast-Conserving Treatment in Patients With Breast Cancer With BRCA VariantsJanghee Lee, Jai Min Ryu, Hong Kyu Kim, et al.
Breast (Edinburgh, Scotland)|June 17, 2025
Body mass index and progesterone receptor in postmenopausal ER-positive/HER2-negative breast cancer: A nation-wide study in Korean breast cancer society and the multi-institutional cohortJanghee Lee, Soong June Bae, Hong Kyu Kim, et al.
Pageof 24